1. Pink Sheet
  2. >>Biosimilars & Generics
  3. >>Biosimilars

Biosimilars' Pediatric Pressures Could Push Them Toward Interchangeability

 
• By Derrick Gingery

Study and formulation requirements under PREA mean that interchangeability application might not be much more of a leap.

ChildInjection_1200x675

Pediatric development laws could wind up directing biosimilar sponsors toward interchangeability whether they want it or not.

For Sandoz Inc. and its GP2015, a proposed biosimilar to Amgen Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Biosimilars

More from Biosimilars & Generics